First Trust Advisors LP Has $2.48 Million Stock Position in Merit Medical Systems, Inc. $MMSI

First Trust Advisors LP boosted its stake in shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) by 479.1% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 35,907 shares of the medical instruments supplier’s stock after purchasing an additional 29,706 shares during the period. First Trust Advisors LP’s holdings in Merit Medical Systems were worth $2,475,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently made changes to their positions in MMSI. AQR Capital Management LLC grew its stake in shares of Merit Medical Systems by 7.3% in the first quarter. AQR Capital Management LLC now owns 16,361 shares of the medical instruments supplier’s stock valued at $1,730,000 after buying an additional 1,114 shares in the last quarter. Goldman Sachs Group Inc. raised its position in Merit Medical Systems by 16.9% during the first quarter. Goldman Sachs Group Inc. now owns 719,313 shares of the medical instruments supplier’s stock worth $76,039,000 after acquiring an additional 103,878 shares in the last quarter. EverSource Wealth Advisors LLC lifted its stake in Merit Medical Systems by 745.9% in the second quarter. EverSource Wealth Advisors LLC now owns 922 shares of the medical instruments supplier’s stock valued at $86,000 after acquiring an additional 813 shares during the last quarter. Cerity Partners LLC lifted its stake in Merit Medical Systems by 9.1% in the second quarter. Cerity Partners LLC now owns 3,019 shares of the medical instruments supplier’s stock valued at $282,000 after acquiring an additional 251 shares during the last quarter. Finally, California Public Employees Retirement System grew its position in shares of Merit Medical Systems by 0.5% in the 2nd quarter. California Public Employees Retirement System now owns 148,607 shares of the medical instruments supplier’s stock valued at $13,892,000 after acquiring an additional 755 shares during the period. Institutional investors and hedge funds own 99.66% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the stock. Wells Fargo & Company upped their target price on shares of Merit Medical Systems from $74.00 to $83.00 and gave the company an “equal weight” rating in a report on Friday, July 31st. Needham & Company LLC lifted their price target on Merit Medical Systems from $90.00 to $101.00 and gave the stock a “buy” rating in a report on Friday, July 31st. JPMorgan Chase & Co. boosted their price target on Merit Medical Systems from $77.00 to $95.00 and gave the stock an “overweight” rating in a research report on Friday, July 31st. Raymond James Financial reaffirmed an “outperform” rating and issued a $100.00 price objective on shares of Merit Medical Systems in a research report on Friday, July 31st. Finally, Weiss Ratings upgraded Merit Medical Systems from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday. Eight equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $100.30.

Merit Medical Systems Trading Up 1.5%

Shares of NASDAQ:MMSI opened at $89.04 on Friday. Merit Medical Systems, Inc. has a 12-month low of $59.74 and a 12-month high of $94.75. The business has a 50 day moving average of $72.21 and a 200-day moving average of $71.97. The company has a quick ratio of 2.79, a current ratio of 4.20 and a debt-to-equity ratio of 0.44. The stock has a market cap of $5.32 billion, a PE ratio of 36.79, a P/E/G ratio of 2.21 and a beta of 0.49.

Merit Medical Systems (NASDAQ:MMSI) last issued its quarterly earnings data on Thursday, July 30th. The medical instruments supplier reported $1.19 EPS for the quarter, beating analysts’ consensus estimates of $0.96 by $0.23. The firm had revenue of $418.84 million for the quarter, compared to analyst estimates of $405.25 million. Merit Medical Systems had a return on equity of 13.75% and a net margin of 9.22%.The company’s revenue for the quarter was up 9.5% on a year-over-year basis. During the same period in the prior year, the firm posted $1.01 EPS. Merit Medical Systems has set its FY 2026 guidance at 4.250-4.350 EPS. As a group, equities research analysts forecast that Merit Medical Systems, Inc. will post 3.81 earnings per share for the current year.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.